| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 47 |
| 1 | ASPIRIN 325 MG | 43 |
| 2 | ASPIRIN 81 MG | 43 |
| 3 | RIVAROXABAN | 27 |
| 4 | CLOPIDOGREL | 21 |
| 5 | DICLOFENAC SODIUM | 19 |
| 6 | FUROSEMIDE | 19 |
| 7 | CLOPIDOGREL BISULFATE | 18 |
| 8 | DICLOFENAC | 18 |
| 9 | AMLODIPINE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED | 1 | 0.0147 |
| 2 | COUMARIN | 1 | 0.0061 |
| 3 | HETASTARCH | 1 | 0.0059 |
| 4 | ANDEXANET ALFA | 1 | 0.0014 |
| 5 | BODY CLEANSER | 1 | 0.0014 |
| 6 | DESMOPRESSIN ACETATE | 5 | 0.0013 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 10 | 0.0012 |
| 8 | NICARDIPINE | 5 | 0.0011 |
| 9 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 73 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 48 |
| 2 | Factor Xa Inhibitor [EPC] | 31 |
| 3 | Kinase Inhibitor [EPC] | 22 |
| 4 | Loop Diuretic [EPC] | 19 |
| 5 | Calcium Channel Blocker [EPC] | 17 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 17 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 17 |
| 8 | Corticosteroid [EPC] | 15 |
| 9 | beta-Adrenergic Blocker [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 1 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 2 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Oxytocic [EPC] | 1 | 0.0003 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 6 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 7 | Thiazide-like Diuretic [EPC] | 7 | 0.0002 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 9 | Glycopeptide Antibacterial [EPC] | 10 | 0.0002 |